SCHEMBL9502806

SCHEMBL9502806

CC(=O)N(Cc1ccccc1)c1c(F)c(F)cc(F)c1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSPO P30536 2/20 0.49
▸ CRHBP P24387 1/20 0.42
▸ CRHR2 Q13324 1/20 0.42
▸ TDP1 Q9NUW8 2/20 0.41
▸ LTB4R2 Q9NPC1 1/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ HTR6 P50406 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.39
▸ HTT P42858 3/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ APAF1 O14727 1/20 0.38
▸ CYP3A4 P08684 1/20 0.37
▸ ACHE P22303 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9500955 0.81 TSPO (0.43) TSPOCRHBPCRHR2TDP1RAB9A
SCHEMBL29137813 0.74 MEN1 (0.40) TSPOCRHBPCRHR2TDP1LTB4R2
SCHEMBL3095422 0.69 TSPO (0.58) TSPOCRHBPCRHR2LTB4R2RAB9A
SCHEMBL5694553 0.69 TSPO (0.72) TSPOCRHBPCRHR2LTB4R2RAB9A
SCHEMBL2884029 0.69 CRHBP (0.53) CRHBPCRHR2TDP1RAB9AMEN1
SCHEMBL9501324 0.69 TSHR (0.46) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL12560893 0.69 TSPO (0.57) TSPOCRHBPCRHR2TDP1LTB4R2
SCHEMBL19650787 0.68 TSPO (0.56) TSPOCRHBPCRHR2LTB4R2RAB9A
SCHEMBL12536635 0.67 TSPO (0.55) TSPOCRHBPCRHR2LTB4R2RAB9A
SCHEMBL1927316 0.66 TDP1 (0.57) TSPOTDP1RAB9AKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1021967-C Process for preparing quinoline derivatives DAINIPPON PHARMACEUTICAL CO (JP) 1993-09-01 — — CN disclosed
EP-0312085-B1 NOVEL QUINOLINE DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND ANTIBACTERIAL AGENT CONTAINING THEM Dainippon Pharmaceutical Co., Ltd. (JP) 1993-05-12 — — EP disclosed
US-5164392-A Active against streptococci and staphylococci DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1992-11-17 — — US disclosed
US-5013841-A Oxo quinoline derivatives DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1991-05-07 — — US disclosed
CN-1033996-A New quinoline and their preparation method DAINIPPON PHARMACEUTICAL CO (JP) 1989-07-19 — — CN disclosed
EP-0312085-A2 Novel quinoline derivatives, processes for preparation thereof and antibacterial agent containing them Dainippon Pharmaceutical Co., Ltd. (JP) 1989-04-19 — — EP disclosed
Send feedback